References
- Eder, AF, Manno, C.S. Alloimmune hemolytic disease of the fetus and newborn. In Wintrobe’s Clinical Hematology, 11th ed. (Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader BE, (eds). Philadelphia, PA: Lippincott, Williams & Wilkins, 2004.
- Moise KJ. Red blood cell alloimmunization in pregnancy. Semin Hematol 2005; 42:169-78.
- Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. J Am Med Assoc 1991;265:3270–4.
- Joseph KS, Kramer MS. The decline in Rh hemolytic disease: should Rh prophylaxis get all the credit? Am J Public Health 1998;88:209–15.
- Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2002. Natl Vital Stat Rep 52:1-116, 2002.
- Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.
- Moise KJ. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75–81.
- Heddle NM, Klama L, Frassetto R, et al. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993;23:217–20.
- Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272-5.
- Van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003;17:31-44.
- van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gyecol 2005; 192:171-7.
- Prevention of RhD alloimmunization. ACOG Practice Bulletin Number 4. Washington, DC: American College of Obstetricians and Gynecologists, May 1999.
- Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445–52.
- Garratty G, Do we need to be more concerned about weak D antigens? Transfusion 2005;45: 97-101.
- Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA, Partial D, weak D types and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005; 45:1554-60.
- Cannon M, Pierce R, Taber EB, Schucker J. Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet Gynecol 2003;102:1143-5. Comments: Obstet Gynecol 2004;104:193-5.
- Domen RE. Polices and procedures related to weak D phenotype testing and Rh immune globulin administration. Arch Pathol Lab Med 2000;124:1118-21.
- AABB Standards for Blood Banks and Transfusion Services, 23rd ed. Bethesda, MD: AABB, 2004.
- de Silva M, Engelfriet CP, Reesink HW, Current status of immunoprophylaxis with anti-D immunoglobulin. Vox Sang 2003;85:328-37.
- Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156: 154-8.
- Pourbabak S, Rund CR, Crookston KP. Three cases of massive fetomaternal hemorrhage presenting without clinical suspicion. Arch Pathol Lab Med 2004;128:463-5.
- Means ND, Bandarenko N, Moise JR KJ, Brecher ME. Likelihood of D heterozygosity in Mestizo Mexicans and Mexican Americans. Immunohematol 2001; 17:22-3.
- Singleton BK, Green CA, Avent ND, Martin PG, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95: 12-18.
- Kim JY, Kim SY, Kim CA, Yon GS, Park SS. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005;45:345-52.
- Heckerling PS, Verp MS. Amniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis. J Clin Epidemiol 1991; 44:457-70.
- Bianchi DW, Avent ND, Costa JM, Van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for prime(r) time. Obstet Gynecol 2005; 106:682-3.
- Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996;93:705-8.
- Oepkes D, Seaward PG, Vandenbussche F, Windrim R, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156-64.
- Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-K antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
- Denomme GA, Ryan G, Seaward PGR, Kelly EN, Fernandes BJ. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Transfusion 2004;44:1357-60.
- Herschel M, Karrison T, Wen M, et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antigen test-negative neonates. Pediatrics 2002;110: 127-30.
- Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Pediatr Child Health. 2005;41:504-7.
- Biondi CS, Cotorruelo CM, Ensinck A, Racca LL, Racca AL. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood destruction. Clin Lab 2004;50:265-70.
- American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia, Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
- Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Eng J Med 2006;354:1889-900.